Effect of low and high dose of favipiravir on ovarian and reproductive function in female rats: Biochemical and histopathological evaluation     
Yazarlar (7)
Serdar Balcı
Başkent Üniversitesi, Türkiye
Çağdaş Çöllüoğlu
Başkent Üniversitesi, Türkiye
Bülent Yavuzer
Seval Bulut
Türkiye
Fikret Altındağ
Van Yüzüncü Yıl Üniversitesi, Türkiye
Doç. Dr. Nergis AKBAŞ Erzincan Binali Yıldırım Üniversitesi, Türkiye
Halis Süleyman
Erzincan Binali Yıldırım Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı General physiology and biophysics
Dergi ISSN 1338-4325 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 01-2022
Cilt No 41
Sayı 5
Sayfalar 457 / 463
DOI Numarası 10.4149/gpb_2022036
Makale Linki http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=7846&category_id=181&option=com_virtuemart&vmcchk=1&Itemid=1
Özet
Favipiravir is a drug which shows antiviral activity by inhibiting RNA-dependent RNA polymerase. Favipiravir causes severe adverse effects at high doses. The aim of this study was to investigate the effects of low and high dose favipiravir on ovarian and reproductive function in female rats. The rats were divided into three groups: HG group (healthy rats), FAV-100 group (rats administered 100 mg/kg favipiravir), and FAV-400 group (rats administered 400 mg/kg favipiravir) with 12 rats in each group. Favipiravir was administered orally twice daily for 1 week. Six rats from each group were euthanized and their ovaries were removed. Oxidative and antioxidant parameters were measured in ovarian tissues and examined histopathologically. The remaining animals were kept to breed. Animals receiving favipiravir had increased oxidant content, decreased antioxidant activity, decreased histopathological damage, infertility, and gestational delay. Favipiravir treatment should be used with caution, especially in women of reproductive age.
Anahtar Kelimeler
Favipiravir | Ovarian tissue | Reproductive function